Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India
New Delhi: Serious legal gaps in the Drugs and Cosmetics Act, 1940, combined with acute shortages of manpower and infrastructure, continue to impede the Central Drugs Standard Control Organisation (CDSCO)…
Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act
Patna: In a significant ruling that could have far-reaching implications for NDPS drug-related prosecutions involving common pharmaceutical compounds, the Patna High Court has held that Phenothiazine and Promethazine do not…
COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients
Washington: A new study has revealed a previously unknown interaction between two cornerstone Parkinson’s disease medications that could unintentionally reduce treatment effectiveness in some patients. Researchers at Yale School of…
Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested
New Delhi: In a major crackdown on the sale of expired and substandard products, the Central Range team of Delhi Police Crime Branch has arrested one person and seized nearly…
FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development
Washington: On March 18, 2026, the U.S. Food and Drug Administration (FDA) issued a draft guidance titled General Considerations for the Use of New Approach Methodologies in Drug Development. The…
%20In%20Drug%20Development){kind=link}
IPC releases draft NFI-2026 to promote rational use of medicines
Ghaziabad:- The Indian Pharmacopoeia Commission (IPC) has taken a significant step toward strengthening public health systems with the draft release of the National Formulary of India (NFI) 2026, a comprehensive…
Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery
Bharat Mandapam witnessed Spectacle of Crazy Innovations by Maker of Ssi Mantra, Best in class Surgical Robot New Delhi: It was a veritable display of innovative potential and prowess of…
US market to dent India pharma earnings even as domestic growth remains firm
New Delhi: India’s pharmaceutical sector is likely to witness steady domestic growth but continued pressure in the US market in the fourth quarter of FY26, according to a report by…
Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg
Biocon Pharma, a subsidiary of Biocon, today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for Dapagliflozin Tablets, 5 mg and 10 mg. The…
Healthcare, pharma sector to create 2-2.5 million new jobs by 2030
Mumbai, India’s healthcare and pharmaceutical sector is set to enter a capability-led growth phase, potentially creating 2 to 2.5 million new jobs by 2030, while 30 to 35 per cent…
Over 45% eye infection bacteria drug-resistant, study flags AMR threat
Hyderabad: A joint study by CSIR-Centre for Cellular and Molecular Biology (CCMB) and LV Prasad Eye Institute (LVPEI) has flagged a worrying rise in antimicrobial resistance (AMR) in eye infections,…
Lokayukta Police Launch Multi-City Raids on ADC; Rs 3.37 Crore in Disproportionate Assets Unearthed Across Karnataka
Mangaluru: In a significant anti-corruption drive, Karnataka Lokayukta police conducted simultaneous searches at multiple properties linked to Babu B N, Assistant Drug Controller in the office of the Regional Deputy Drug…
Alembic Pharma Gets USFDA Nod for Dapagliflozin
New Delhi: Alembic Pharmaceuticals Ltd on Tuesday said it has received final approval from the US health regulator for its generic version of dapagliflozin tablets used to control blood sugar…
On World Health Day ‘CAHO Na Patient Se Pyaar Hai’
Chennai hosts 3 Day International Conference CAHOCON on Patient Safety in Hospitals starting April 10 New Delhi: Patient safety in hospitals is a global concern, more so in India. It…
Supreme Court willing to understand Angst of Doctors regarding Consumer Protection Act
Listing of PIL by AHPI raises hope in the community New Delhi: The PIL (Public Interest Litigation) to examine Plea on Applicability of Consumer Protection Act to Medical Professionals is…
Aurobindo Pharma Board approves ₹800 cr share buyback plan
Generic drugmaker is proposing to buyback more than 54.23 lakh equity shares at ₹1,475 each, fixes April 17, 2026 as the record date Aurobindo Pharma’s Board has approved the generic…
Three held for cheating SCB Hospital patients on promise of arranging blood
Cuttack: Police have busted a broker racket operating around the SCB Medical College and Hospital in Cuttack and arrested three accused who allegedly cheated patients and their attendants on the…
NATHEALTH resolves to evolve to fit The Bill of Viksit Bharat
Dr Sangita Reddy packs a punch as New President of Organization New Delhi: 12th NATHEALTH Arogya Bharat Summit 2026 culminated as the exposition of roadmap of healthcare commensurate with Viksit…
Cancer drug makers seek 50% price hike as platinum surge hits production viability
Mumbai | Delhi: Manufacturing of cancer medicines such as carboplatin, oxaliplatin and cisplatin has become unviable due to a surge in the price of platinum, a critical component in these…
CDRI’s new research hub in Lucknow to facilitate innovation in drug discovery & development
Lucknow: Marking 70 years of its inception, the Central Drug Research Institute (CDRI) in Lucknow launched a new and advanced research facility called Common Research and Technology Development Hub (CRTDH).…
